An interview with Dr. Colin Collins titled "Genomics in Prostate Cancer and Beyond" was published today in Gene Online. Dr. Collins discusses what brought him to the Vancouver Prostate Centre, his past and current research, and the importance of team science. Click here to read the interview (link opens in new window).
Today, Prostate Cancer Canada and the Movember Foundation announced $4 million for three leading Canadian researchers on projects surrounding the use of biological markers in the prediction of how well prostate cancer will respond to treatment.
Dr. Yuzhuo Wang was inducted as a Fellow of the Canadian Academy of Health Sciences. He received the honour in a presentation by Dr. Linda Rabeneck, President of the CAHS in a ceremony held in Vancouver on September 13 at the Marriott Pinnacle Downtown Hotel, Vancouver, BC. You can view the full CAHS annoucment here; the entry for Dr. Wang is:
Each year, the UBC Faculty of Medicine recognizes faculty and staff members for excellence in teaching, research, administration, innovation and public service. This year, Dr Zoubeidi was awarded a UBC Faculty of Medicine Distinguished Achievement Award for Excellence in Basic Science Research, in recognition of meritorious performance.
Her Excellency the Right Honourable Julie Payette, Governor General of Canada, invested Dr. Martin Gleave as a Member of the Order of Canada on Thursday, September 6, 2018, at Rideau Hall. Dr. Gleave's appointment was reported on January 6 by VCHRI News and re-posted on VPC News on Jan 8.
Dr Martin Gleave is the recipient of the fifth annual Dr Chew Wei Memorial Prize in Cancer Research for his work to improve outcomes from prostate cancer, which has spanned surgery, molecular manipulation in the search for new treatments, and managing the challenge of taking lab discoveries to market. The UBC Faculty of Medicine bestows this award annually to a Canadian physician or scientist who makes outstanding co
Drs. Zoubeidi, Black and So are PIs on three CIHR Project Grants that were funded in the March 2018 competition. The funded projects are:
Dr. Amina Zoubeidi: Hormone therapy induces reprogramming to drive aggressive prostate cancer ($669,376 over 5 years)
- Ranked 1st of 39 projects in the Cancer Biology & Therapeutics 2 Committee's review panel
Drs. Peter Black & Purang Abolmaesumi: Multi-centre Temporal Ultrasound Image Analysis for Prostate Cancer Diagnosis ($1,158,976 over 5 years)
